Bristol-Myers Squibb Company share price logo

Bristol-Myers Squibb Company

NYSE: BMY

Large Cap

$57.34

-0.88

(-1.51%)

Live

as on

Bristol-Myers Squibb Company Stock Performance

as on May 5, 2026 at 5:07 am IST

  • Day's Low

    Day's High

    $56.93
    $58.00
    downward going graph

    0.72%

    Downside

    1.15%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $42.52
    $62.89
    downward going graph

    25.85%

    Downside

    9.67%

    Upside

    downward going graph

Bristol-Myers Squibb Company share price movements today

Previous Close
$58.22
Open
$57.54
Volume
6.2M
Day's Low - High
$56.93 - $58.00
52 Week Low - High
$42.52 - $62.89

Bristol-Myers Squibb Company Historical Returns

1 Month Return
-2.32 %
3 Month Return
+ 1.04 %
1 Year Return
+ 15.13 %
3 Year Return
-12.87 %
5 Year Return
-8.96 %

Bristol-Myers Squibb Company Stock Fundamentals & Key Indicators

Check Bristol-Myers Squibb Company market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$118.9B

EPS (TTM)

6.3185

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.09%

PE Ratio (TTM)

16.31

Industry PE ratio

19.333

PEG Ratio

23.1768

EBITDA

18.6B

Revenue (TTM)

48.5B

Profit Margin

15.01%

Return On Equity TTM

38.73%

Bristol-Myers Squibb Company Stock Valuation

Track how Bristol-Myers Squibb Company P/E has moved over time to understand its valuation trends.

Bristol-Myers Squibb Company in the last 5 years

  • Overview

  • Trends

Lowest (7.10x)

December 31, 2023

Today (16.31x)

May 4, 2026

Industry (19.33x)

May 4, 2026

Highest (54.19x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 16.31x

Bristol-Myers Squibb Company vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bristol-Myers Squibb Company with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
HOLD$118.9B-8.96%16.3115.01%
BUY$286.4B249.03%27.8617.19%
BUY$862.0B411.87%34.2534.99%
BUY$365.4B81.39%100.785.79%
BUY$546.9B35.42%26.3321.83%

Stock Returns calculator for Bristol-Myers Squibb Company Stock including INR - Dollar returns

The Bristol-Myers Squibb Company stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bristol-Myers Squibb Company investment value today

Current value as on today

₹1,27,878

Returns

₹27,878

(+27.88%)

Returns from Bristol-Myers Squibb Company Stock

₹13,387 (+13.39%)

Dollar Impact

₹14,490 (+14.49%)

Analyst Recommendation on Bristol-Myers Squibb Company Stock

Based on 31 analysts

HOLD

32.26%

Buy

64.52%

Hold

3.23%

Sell

Based on 31 analysts, 64.52% of analysts recommend a 'HOLD' rating for Bristol-Myers Squibb Company. Average target price of $63.32

Bristol-Myers Squibb Company Share Price Target

Get share price movements and forecasts by analysts on Bristol-Myers Squibb Company.

What analysts predicted

9.44%UPSIDE

Target Price

$63.32

Current Price

$57.34

Analyzed by

31 Analysts

Target

$63.32

Bristol-Myers Squibb Company target price $63.32, a slight upside of 9.44% compared to current price of $57.34. According to 31 analysts rating.

Bristol-Myers Squibb Company Stock’s Investor Sentiment and Interest

Search interest for Bristol-Myers Squibb Company Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:22% versus previous 30 day period

Bristol-Myers Squibb Company Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
11,477
11,865
12,201
11,892
12,342
11,201
12,269
12,222
12,502
11,489
Gross Profit
6,492
6,590
6,801
6,617
7,424
7,340
8,070
8,787
8,405
8,068
Operating Income
1,952
1,535
2,584
2,288
2,531
3,521
4,117
3,639
1,419
3,271
EBITDA
4,454
-8,559
4,403
4,773
2,551
4,477
3,287
4,587
2,194
3,708
Interest Expense
316
425
521
505
496
494
485
480
51
-
Depreciation
2,464
2,532
2,596
2,592
1,880
1,012
1,011
1,011
977
-
Income Before Tax
1,674
-11,516
1,286
1,676
175
2,971
1,773
3,114
1,470
3,240
Income Tax Expense
-88
392
-398
461
99
509
460
919
384
561
Net Income
1,762
-11,911
1,680
1,211
72
2,456
1,310
2,201
1,086
2,678
Net Profit Margin
15.35%
-100.39%
13.77%
10.18%
0.58%
21.93%
10.68%
18.01%
8.69%
23.31%

Bristol-Myers Squibb Company Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
19,427
20,776
22,561
26,145
42,518
46,385
46,159
45,006
48,300
48,194
Gross Profit
14,495
14,958
16,075
17,250
21,700
26,761
26,490
25,357
27,432
32,602
Operating Income
5,179
5,239
6,394
6,439
4,492
9,540
9,271
8,472
9,658
12,696
EBITDA
6,464
6,116
6,788
7,377
4,929
20,118
19,221
19,366
3,168
14,545
Interest Expense
167
196
183
656
1,420
1,334
1,232
1,166
1,947
1,510
Depreciation
-
789
637
1,746
10,380
10,023
9,595
9,817
9,600
4,011
Income Before Tax
5,915
5,131
5,968
4,975
-6,871
8,098
7,713
8,440
-8,379
9,328
Income Tax Expense
1,408
4,156
1,021
1,515
2,124
1,084
1,368
400
554
2,272
Net Income
4,457
1,007
4,920
3,439
-8,995
6,994
6,327
8,025
-8,948
7,053
Net Profit Margin
22.94%
4.85%
21.81%
13.15%
-21.16%
15.08%
13.71%
17.83%
-18.53%
14.63%

Bristol-Myers Squibb Company Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-11,908
1,684
1,215
76
2,462
1,313
2,195
1,085
2,678
Operating Cash Flow
2,834
2,326
5,591
4,439
1,954
3,917
6,311
1,974
1,104
Investing Cash Flow
-19,618
-1,319
-219
-196
-499
-473
-1,702
-1,458
-131
Financing Cash Flow
14,644
-4,023
-3,852
-1,642
-993
-1,836
-1,490
-6,029
-1,560
Change in Cash
-2,185
-3,038
1,597
2,454
528
1,736
3,115
-5,508
-635

Bristol-Myers Squibb Company Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
975
4,947
3,460
-8,995
7,014
6,345
8,040
-8,933
7,055
Operating Cash Flow
5,275
7,066
8,067
14,052
16,207
13,066
13,860
15,190
14,156
Investing Cash Flow
-66
-2,000
-9,770
-10,859
-538
-1,062
-2,295
-21,352
-4,132
Financing Cash Flow
-4,077
-3,535
7,621
-1,151
-16,224
-16,962
-9,416
5,127
-10,348
Change in Cash
1,184
1,490
5,909
2,153
-657
-4,991
2,194
-1,172
-137

Mutual Funds that own Bristol-Myers Squibb Company Stock

Check out the Mutual Funds with significant holdings in Bristol-Myers Squibb Company.

Global Institutional Holdings in Bristol-Myers Squibb Company

Funds
Holdings
Bank of New York Mellon Corp
1.2%
Bank of New York Mellon Corp
1.02%
Northern Trust Corp
1.21%
Independent Franchise Partners LLP
1.02%
Dimensional Fund Advisors, Inc.
0.89%

Bristol-Myers Squibb Company News & Key Events

  • img

    Today's Timeline - 29 April

    Wed, 10:30 PM

    -

    Bristol-Myers Squibb beats revenue expectations, with Q1 results anticipated to show a 4.5% decline year on year.

    Thu, 06:39 AM

    -

    Bristol-Myers Squibb issues upbeat 2026 guidance, projecting $48.3 billion revenue, exceeding Wall Street expectations.

Insights on Bristol-Myers Squibb Company

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Bristol-Myers Squibb Co. has shown strong profit growth over the last two quarters. Their net profit increased from $1.08 billion to $2.67 billion, which reflects an average growth of 59.5% per quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, ASTRAZENECA PLC has given 155.0% return, outperforming this stock by 139.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ASTRAZENECA PLC has given 148.4% return, outperforming this stock by 161.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Bristol-Myers Squibb Co. has experienced a decline in revenue for the past two quarters. Revenue dropped from $12.50 billion to $11.48 billion, showing an average decrease of 8.1% per quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BMY stock has moved down by -2.3%

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, and to a lesser extent, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.
OrganisationBristol-Myers Squibb Company
HeadquartersRoute 206 & Province Line Road, Princeton, NJ, United States, 08543
IndustryDrug Manufacturers - General
CEODr. Christopher S. Boerner Ph.D.
E-voting on sharesClick here to vote

Key Management of Bristol-Myers Squibb Company

Name

Title

Ms. Ahn Amanda Poole

Executive VP & Chief People Officer

Mr. Adam Lenkowsky

Executive VP & Chief Commercialization Officer

Mr. Cristian Massacesi M.D.

Executive VP, Chief Medical Officer & Head of Development

Ms. Karin Shanahan

Executive VP, Chief Supply Chain & Operations Officer

Mr. Charles E. Triano

SVP & Head of Investor Relations

Ms. Cari Gallman

Executive VP, General Counsel & Chief Policy Officer

Dr. Joseph J. Eiden Jr.

Head of Medical Affairs

Dr. Christopher S. Boerner Ph.D.

CEO & Chairman

Mr. David V. Elkins

Executive VP & CFO

Mr. Greg Meyers

Executive VP and Chief Digital & Technology Officer

FAQs

What is Bristol-Myers Squibb Company share price today?

Bristol-Myers Squibb Company share price today is $57.34 as on . Bristol-Myers Squibb Company share today touched a day high of $58 and a low of $56.93.

What is the 52 week high and 52 week low for Bristol-Myers Squibb Company share?

Bristol-Myers Squibb Company share touched a 52 week high of $62.89 on and a 52 week low of $42.52 on . Bristol-Myers Squibb Company stock price today i.e. is trending at $57.34,which is 8.82% down from its 52 week high and 34.85% up from its 52 week low.

What is Bristol-Myers Squibb Company's market capitalisation today?

Bristol-Myers Squibb Company market capitalisation is $0.12T as on .

How to invest in Bristol-Myers Squibb Company Stock (BMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bristol-Myers Squibb Company on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bristol-Myers Squibb Company Shares that will get you 0.0262 shares as per Bristol-Myers Squibb Company share price of $57.34 per share as on May 4, 2026 at 11:37 pm IST.

What is the minimum amount required to buy Bristol-Myers Squibb Company Stock (BMY) from India?

Indian investors can start investing in Bristol-Myers Squibb Company (BMY) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Bristol-Myers Squibb Company stock (as per the Rupee-Dollar exchange rate as on ). Based on Bristol-Myers Squibb Company share’s latest price of $57.34 as on May 4, 2026 at 11:37 pm IST, you will get 0.1744 shares of Bristol-Myers Squibb Company. Learn more about fractional shares .

What are the returns that Bristol-Myers Squibb Company has given to Indian investors in the last 5 years?

Bristol-Myers Squibb Company stock has given -8.96% share price returns and 28.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?